Gabriela Corrêa Carvalho

Ms. Gabriela Corrêa Carvalho

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
GCGabriela Corrêa Carvalho
Gabriela Corrêa Carvalho
BCBruna Almeida Furquim de Camargo
Bruna Almeida Furquim de Camargo
JAJennifer Thayanne Cavalcante de Araújo
Jennifer Thayanne Cavalcante de Araújo
Marlus ChorilliMarlus Chorilli
Marlus Chorilli

1 June 2021 in Carbohydrate Polymers
Verified
Journal Article
Closed access
VAVictor Hugo Sousa Araujo
Victor Hugo Sousa Araujo
MSMaurício Palmeira Chaves de Souza
Maurício Palmeira Chaves de Souza
GCGabriela Corrêa Carvalho
Gabriela Corrêa Carvalho
Jonatas DuarteJonatas Duarte
Jonatas Duarte
Marlus ChorilliMarlus Chorilli
Marlus Chorilli

16 March 2021 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
MSMaurício Palmeira de Souza
Maurício Palmeira de Souza
BCBruna Almeida Furquim de Camargo
Bruna Almeida Furquim de Camargo
LSLarissa Spósito
Larissa Spósito
GFGiovanna Capaldi Fortunato
Giovanna Capaldi Fortunato
GCGabriela Corrêa Carvalho
Gabriela Corrêa Carvalho
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Due to the high adaptability of Helicobacter pylori and the low targeting specificity of the drugs normally used in pharmacological therapy, the strains are becoming increasingly resistant to these drugs, making it difficult to eradicate the infection. Thus, the search for new therapeutic approaches has been considered urgent. The incorporation of drugs in advanced drug delivery systems, such as nano and microparticles, would allow the improvement of the retention time in the stomach and the prolongation of drug release rates at the target site. Because of this, the present review article aims to highlight the use of micro and nanoparticles as important technological tools for the treatment of H. pylori infections, focussing on the main nanotechnological systems, including nanostructured lipid carriers, liposomes, nanoemulsion, metallic nanoparticles, and polymeric nanoparticles, as well as microtechnological systems such as gastroretentive dosage forms, among them mucoadhesive, magnetic and floating systems were highlighted.

14 August 2020 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
VAVictor Hugo Sousa Araujo
Victor Hugo Sousa Araujo
Jonatas DuarteJonatas Duarte
Jonatas Duarte
GCGabriela Corrêa Carvalho
Gabriela Corrêa Carvalho
ASAmanda Letícia Polli Silvestre
Amanda Letícia Polli Silvestre
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
The crescent number of cases of candidiasis and the increase in the number of infections developed by non-albicans species and by multi-resistant strains has taken the attention of the scientific community, which has been searching for new therapeutic alternatives. Among the alternatives found the use of nanosystems for delivery of drugs already commercialized and new biomolecules have grown, in order to increase stability, solubility, optimize efficiency and reduce adverse effects. In view of the growing number of studies involving technological alternatives for the treatment of candidiasis, the present review came with the intention of gathering studies from the last two decades that used nanotechnology for the treatment of candidiasis, as well as analysing them critically and pointing out the future perspectives for their application with this purpose. Different studies were considered for the development of this review, addressing nanosystems such as metallic nanoparticles, mesoporous silica nanoparticles, polymeric nanoparticles, liposomes, nanoemulsion, microemulsion, solid lipid nanoparticle, nanostructured lipid carrier, lipidic nanocapsules and liquid crystals; and different clinical presentations of candidiasis. As a general overview, nanotechnology has proven to be an important ally for the treatment against the diversity of candidiasis found in the clinic, whether in increasing the effectiveness of commercialized drugs and reducing their adverse effects, as well as allowing exploring more effectively properties therapeutics of new biomolecules.

4 September 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
LSLarissa Spósito
Larissa Spósito
GCGabriela Corrêa Carvalho
Gabriela Corrêa Carvalho
Priscileila Colerato FerrariPriscileila Colerato Ferrari
Priscileila Colerato Ferrari
Marlus ChorilliMarlus Chorilli
Marlus Chorilli

15 May 2020 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
GCGabriela Corrêa Carvalho
Gabriela Corrêa Carvalho
RSRafael Miguel Sábio
Rafael Miguel Sábio
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Lycopene (LYC), a natural compound responsible for the red color of some fruits like pink grapefruit, red guava, watermelon, papaya and, mainly, present in tomatoes (Solanum lycopersicum). LYC has been extensively studied because of its various pharmacological properties such as antioxidant, cardioprotective, hypocholesterolemic, antineophasic, photoprotection, antidiabetic and antimicrobial activity. However, LYC uses in therapy is limited due to its insolubility in aqueous solvents, resulting in low bioavailability and stability. In order to overcome these drawbacks, it is essential to use of organic nanocarriers for LYC controlled release. Up to now, the description of LYC-loaded organic nanocarriers are scarce, mainly related to organic nanosystems based on lipid nanostructures such as nanoemulsions (NE), liposomes (LP), niosomes (NI), nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN). Taking into account the development of new formulations, is indispensable the use of sensitive and suitable analytical methods previously validated. Among the analytical methods described here, high-performance liquid chromatography (HPLC) stands out due to its good accuracy, precision and desirable detection limit. In this review, we highlights the main biological and physicochemical properties of LYC, as well as LYC-based organic nanocarriers for controlled drug delivery and the analytical methods described in literature to determine LYC in any kind of matrix.